Orega Biotech

Develops monoclonal antibodies to treat cancer

placeEcully, Auvergne Rhone Alpes, France calendar_todayFounded 2010 groups7 employees language orega-biotech.com

Innovation

14 patent families (9 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,252 times.

YearFilings
20153
20161
20175
20185
20195
20204
20214
20223
20234
20243
20254
20261

Investor mix

9 investors on record.

Investor typeCountShare
Venture capital333%
Private equity222%
Other / undisclosed444%
Coming soon